Compare PHAR & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | CRI |
|---|---|---|
| Founded | 1988 | 1865 |
| Country | Netherlands | United States |
| Employees | N/A | 15400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2020 | 2002 |
| Metric | PHAR | CRI |
|---|---|---|
| Price | $16.46 | $37.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $38.33 | $34.00 |
| AVG Volume (30 Days) | 8.0K | ★ 998.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.53 |
| Revenue | N/A | ★ $2,898,426,000.00 |
| Revenue This Year | $10.04 | $4.57 |
| Revenue Next Year | $2.51 | $1.12 |
| P/E Ratio | $3,041.22 | ★ $15.01 |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $8.39 | $23.38 |
| 52 Week High | $21.34 | $44.44 |
| Indicator | PHAR | CRI |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 54.07 |
| Support Level | $16.35 | $31.90 |
| Resistance Level | $17.49 | $39.05 |
| Average True Range (ATR) | 0.47 | 1.57 |
| MACD | -0.10 | 0.14 |
| Stochastic Oscillator | 2.50 | 49.89 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.